Related Experiment Video
Updated: Feb 10, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
DDX3X RNA helicase affects breast cancer cell cycle progression by regulating expression of KLF4
Ester Cannizzaro1, Andrew John Bannister1, Namshik Han1
1Department of Pathology and Gurdon Institute, University of Cambridge, Cambridge, UK.
Abstract:
DDX3X is a multifunctional RNA helicase with documented roles in different cancer types. Here, we demonstrate that DDX3X plays an oncogenic role in breast cancer cells by modulating the cell cycle. Depletion of DDX3X in MCF7 cells slows cell proliferation by inducing a G1 phase arrest. Notably, DDX3X inhibits expression of Kruppel-like factor 4 (KLF4), a transcription factor and cell cycle repressor. Moreover, DDX3X directly interacts with KLF4 mRNA and regulates its splicing. We show that DDX3X-mediated repression of KLF4 promotes expression of S-phase inducing genes in MCF7 breast cancer cells. These findings provide evidence for a novel function of DDX3X in regulating expression and downstream functions of KLF4, a master negative regulator of the cell cycle.
Insights
The DDX3X RNA helicase promotes breast cancer cell growth by inhibiting KLF4, a cell cycle repressor. DDX3X
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- DDX3X is an RNA helicase implicated in various cancers.
- Its specific role in breast cancer progression requires further elucidation.
Purpose of the Study:
- To investigate the function of DDX3X in breast cancer cell cycle regulation.
- To identify downstream targets and mechanisms of DDX3X action.
Main Methods:
- Depletion of DDX3X in MCF7 breast cancer cells.
- Analysis of cell cycle progression.
- Assessment of Kruppel-like factor 4 (KLF4) expression and mRNA splicing.
- Evaluation of S-phase inducing gene expression.
Main Results:
- DDX3X depletion induced G1 phase arrest and slowed proliferation in MCF7 cells.
- DDX3X was found to inhibit KLF4 expression.
- DDX3X directly interacted with KLF4 mRNA, regulating its splicing.
- DDX3X-mediated KLF4 repression promoted S-phase gene expression.
Conclusions:
- DDX3X plays an oncogenic role in breast cancer by modulating the cell cycle.
- DDX3X regulates breast cancer cell proliferation through KLF4 inhibition and altered mRNA splicing.
- This study reveals a novel mechanism for DDX3X in breast cancer, involving KLF4 regulation.
Related Concept Videos
DNA Helicases
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Cell Specific Gene Expression

